Global Cell
Culture Media for Vaccine Market, by Media Type (Bovine Derived, Porcine
Derived, and Animal Free/Serum Free Cell Culture), by Application (Human
Vaccine and Animal Vaccine), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,235.5
million in 2017 and is projected to exhibit a CAGR of 7.7% over the forecast period
(2018 – 2026).
Key players in the market are
focused on research and development in order to develop novel research grade
products to cater the need of researchers. For instance, in November 2017,
Proliant Biologicals launched New Zealand manufactured Reagent Grade (Fatty
Acid-Free) BSA. The product is derived from New Zealand-origin healthy animals.
Moreover, increasing number of government initiatives to prevent certain
diseases and epidemic caused due to vaccine-preventable diseases is expected to
boost the market growth. Furthermore, increasing number of countries are
conducting national immunization programs to provide vaccination and promote
awareness regarding advantages of vaccination to fight fatal diseases with
natural immunity among adults as well as children. For instance, in 2015, the
Centers for Disease Control and Prevention (CDC), the Food and Drug
Administration (FDA), and the National Institutes of Health (NIH) partnered
with the U.S. Department of Health and Human Services Biomedical Advanced
Research and Development Authority (BARDA) to support the advanced development
of new and better influenza vaccines as a part of inter-agency government
effort in the U.S.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2608
Browse 33 Market Data Tables and
27 Figures spread through 197 Pages and in-depth TOC on ‘Cell Culture Media for
Vaccine Market’- Global Forecast to 2026, by Media Type (Bovine Derived,
Porcine Derived, and Animal Free/Serum Free Cell Culture), by Application
(Human Vaccine and Animal Vaccine), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa)
Key players in the market are
focused on adopting strategies such as mergers and acquisitions to enhance
their product portfolio. For instance, In November 2015, Merck KGaA, which is a
parent company of Merck Millipore, acquired the U.S.-based life science
company, Sigma-Aldrich Corporation, at US$ 17 Bn through its U.S. subsidiary
EMD Millipore. A combined entity known as MilliporeSigma was formed in the U.S.
market and this acquisition made Merck Millipore one of the top three players
in the global life science market.
Key Takeaways of the Global Cell
Culture Media for Vaccine Market:
The global cell culture media for
vaccine market is expected to exhibit a CAGR of 7.7 % over the forecast period,
owing to increasing prevalence of infectious diseases, increasing number of
government initiatives, and increasing availability of innovative bovine blood
plasma derivatives. For instance, in August 2017, Animal Free Research UK and
the 3Rs-Centre Utrecht Life Sciences launched the Fetal Calf Serum (FCS)-free database.
The database enables researchers to identify serum-free media for specific cell
types, thereby contributing to the adoption of animal free media for research.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/cell-culture-media-for-vaccine-market-2608
Among application type, human
vaccine segment is estimated to hold a dominant position in the cell culture
media for vaccine market in 2018, owing to higher usage of bovine derived serum
products in biotechnology research, vaccine production, cloning, and in vitro
fertilization
Among media type, bovine derived
is estimated to hold a dominant position in the cell culture media for vaccine
market in 2018, as manufacturing of viral vaccines require fetal bovine serum
or other sera as a source of nutrition or growth media for the virus growth
Key players operating in the
global cell culture media for vaccine market include, HiMedia Laboratories,
Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius
AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals,
Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs,
Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian
Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research
Laboratories Pvt. Ltd., and Valneva SE
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2608
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
